栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/11 | 1,807 | 1,838 | 1,722 | 1,726 | -74 | -4.1% | 542,800 |
2020/03/10 | 1,667 | 1,821 | 1,625 | 1,800 | +28 | +1.6% | 729,600 |
2020/03/09 | 1,855 | 1,880 | 1,751 | 1,772 | -176 | -9% | 635,400 |
2020/03/06 | 1,970 | 2,018 | 1,940 | 1,948 | -56 | -2.8% | 383,500 |
2020/03/05 | 2,028 | 2,038 | 1,982 | 2,004 | +10 | +0.5% | 335,700 |
2020/03/04 | 1,972 | 2,060 | 1,957 | 1,994 | -22 | -1.1% | 523,700 |
2020/03/03 | 2,050 | 2,120 | 2,000 | 2,016 | -6 | -0.3% | 851,200 |
2020/03/02 | 1,998 | 2,065 | 1,935 | 2,022 | +125 | +6.6% | 1,278,200 |
2020/02/28 | 1,971 | 1,996 | 1,882 | 1,897 | -159 | -7.7% | 992,500 |
2020/02/27 | 2,088 | 2,130 | 2,045 | 2,056 | -64 | -3% | 759,200 |
2020/02/26 | 2,224 | 2,245 | 2,058 | 2,120 | -126 | -5.6% | 1,235,900 |
2020/02/25 | 2,196 | 2,290 | 2,150 | 2,246 | +6 | +0.3% | 1,107,900 |
2020/02/21 | 2,169 | 2,253 | 2,167 | 2,240 | +69 | +3.2% | 739,100 |
2020/02/20 | 2,193 | 2,206 | 2,140 | 2,171 | -31 | -1.4% | 718,400 |
2020/02/19 | 2,257 | 2,257 | 2,148 | 2,202 | -56 | -2.5% | 1,168,400 |
2020/02/18 | 2,450 | 2,450 | 2,237 | 2,258 | -227 | -9.1% | 2,426,000 |
2020/02/17 | 2,400 | 2,549 | 2,360 | 2,485 | +227 | +10.1% | 3,376,500 |
2020/02/14 | 2,226 | 2,314 | 2,219 | 2,258 | +43 | +1.9% | 1,167,600 |
2020/02/13 | 2,369 | 2,369 | 2,177 | 2,215 | -157 | -6.6% | 1,683,500 |
2020/02/12 | 2,419 | 2,425 | 2,336 | 2,372 | -52 | -2.1% | 1,126,300 |
2020/02/10 | 2,520 | 2,600 | 2,375 | 2,424 | +104 | +4.5% | 2,497,700 |
2020/02/07 | 2,317 | 2,393 | 2,265 | 2,320 | +42 | +1.8% | 912,100 |
2020/02/06 | 2,346 | 2,354 | 2,252 | 2,278 | -31 | -1.3% | 649,300 |
2020/02/05 | 2,285 | 2,366 | 2,218 | 2,309 | +74 | +3.3% | 1,009,300 |
2020/02/04 | 2,405 | 2,473 | 2,200 | 2,235 | -14 | -0.6% | 2,211,000 |
2020/02/03 | 2,209 | 2,310 | 2,167 | 2,249 | +54 | +2.5% | 1,417,700 |
2020/01/31 | 2,203 | 2,253 | 2,163 | 2,195 | +52 | +2.4% | 664,800 |
2020/01/30 | 2,149 | 2,181 | 2,095 | 2,143 | -45 | -2.1% | 736,500 |
2020/01/29 | 2,287 | 2,292 | 2,089 | 2,188 | -49 | -2.2% | 956,800 |
2020/01/28 | 2,343 | 2,359 | 2,215 | 2,237 | -90 | -3.9% | 481,600 |
2020/01/27 | 2,250 | 2,401 | 2,239 | 2,327 | +85 | +3.8% | 661,500 |
2020/01/24 | 2,272 | 2,272 | 2,184 | 2,242 | -16 | -0.7% | 218,000 |
2020/01/23 | 2,293 | 2,314 | 2,237 | 2,258 | -46 | -2% | 328,700 |
2020/01/22 | 2,230 | 2,313 | 2,202 | 2,304 | +91 | +4.1% | 393,900 |
2020/01/21 | 2,185 | 2,218 | 2,175 | 2,213 | +50 | +2.3% | 190,000 |
2020/01/20 | 2,109 | 2,164 | 2,107 | 2,163 | +54 | +2.6% | 121,700 |
2020/01/17 | 2,100 | 2,121 | 2,097 | 2,109 | +26 | +1.2% | 139,100 |
2020/01/16 | 2,154 | 2,155 | 2,083 | 2,083 | -49 | -2.3% | 133,400 |
2020/01/15 | 2,130 | 2,135 | 2,113 | 2,132 | -11 | -0.5% | 76,400 |
2020/01/14 | 2,174 | 2,180 | 2,083 | 2,143 | -13 | -0.6% | 163,500 |
2020/01/10 | 2,145 | 2,172 | 2,140 | 2,156 | +49 | +2.3% | 277,400 |
2020/01/09 | 2,100 | 2,131 | 2,084 | 2,107 | +80 | +3.9% | 186,100 |
2020/01/08 | 2,013 | 2,048 | 1,992 | 2,027 | -17 | -0.8% | 112,300 |
2020/01/07 | 1,995 | 2,045 | 1,994 | 2,044 | +68 | +3.4% | 141,400 |
2020/01/06 | 1,976 | 2,016 | 1,959 | 1,976 | -50 | -2.5% | 104,300 |
2019/12/30 | 2,035 | 2,052 | 2,016 | 2,026 | -9 | -0.4% | 57,200 |
2019/12/27 | 2,050 | 2,062 | 2,035 | 2,035 | -4 | -0.2% | 74,200 |
2019/12/26 | 1,983 | 2,043 | 1,983 | 2,039 | +77 | +3.9% | 132,100 |
2019/12/25 | 2,028 | 2,031 | 1,947 | 1,962 | -70 | -3.4% | 165,100 |
2019/12/24 | 2,038 | 2,053 | 2,026 | 2,032 | -6 | -0.3% | 52,700 |
1251~
1300
件表示中 / 6938件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 223,200円 | +0.4% | -8.4% | 2.37% | 28.65倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 216,600円 | +21.7% | +999.9% | 0.00% | 9.02倍 | 2.98倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
杏林製薬 | 148,200円 | +3.2% | +4.5% | 3.51% | 17.03倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 85,100円 | +22.8% | - | 0.00% | 69.53倍 | 1.11倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
あすかHD | 238,900円 | +0.3% | +2.7% | 2.09% | 13.55倍 | 1.06倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム